Landos Biopharma Stock Gross Profit
| LABPDelisted Stock | USD 4.02 0.15 3.60% |
Landos Biopharma fundamentals help investors to digest information that contributes to Landos Biopharma's financial success or failures. It also enables traders to predict the movement of Landos Stock. The fundamental analysis module provides a way to measure Landos Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Landos Biopharma stock.
Landos |
Landos Biopharma Company Gross Profit Analysis
Landos Biopharma's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Landos Biopharma Gross Profit | 18 M |
Most of Landos Biopharma's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Landos Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Landos Biopharma reported 18 M of gross profit. This is 99.2% lower than that of the Biotechnology sector and 98.11% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.93% higher than that of the company.
Landos Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Landos Biopharma's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Landos Biopharma could also be used in its relative valuation, which is a method of valuing Landos Biopharma by comparing valuation metrics of similar companies.Landos Biopharma is currently under evaluation in gross profit category among its peers.
Landos Fundamentals
| Return On Equity | -0.71 | |||
| Return On Asset | -0.39 | |||
| Current Valuation | 42.67 M | |||
| Shares Outstanding | 3.13 M | |||
| Shares Owned By Insiders | 9.88 % | |||
| Shares Owned By Institutions | 52.04 % | |||
| Number Of Shares Shorted | 1.43 K | |||
| Price To Book | 2.11 X | |||
| Price To Sales | 2.37 X | |||
| Gross Profit | 18 M | |||
| EBITDA | (22.73 M) | |||
| Net Income | (21.93 M) | |||
| Cash And Equivalents | 55.75 M | |||
| Cash Per Share | 1.38 X | |||
| Total Debt | 27 K | |||
| Current Ratio | 8.91 X | |||
| Book Value Per Share | 7.43 X | |||
| Cash Flow From Operations | (20.48 M) | |||
| Short Ratio | 0.08 X | |||
| Earnings Per Share | (4.00) X | |||
| Target Price | 12.71 | |||
| Number Of Employees | 19 | |||
| Beta | 0.14 | |||
| Market Capitalization | 71.68 M | |||
| Total Asset | 38.04 M | |||
| Retained Earnings | (155.36 M) | |||
| Working Capital | 31.79 M | |||
| Net Asset | 38.04 M |
About Landos Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Landos Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Landos Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Landos Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Landos Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Landos Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Landos Stock
Moving against Landos Stock
| 0.87 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.82 | EC | Ecopetrol SA ADR | PairCorr |
| 0.78 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.73 | HYMTF | Hyundai Motor | PairCorr |
| 0.71 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Landos Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Landos Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Landos Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Landos Biopharma to buy it.
The correlation of Landos Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Landos Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Landos Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Landos Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world |